Umer Majeed Khaja | Cancer Biology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Umer Majeed Khaja
SKIMS, Srinagar, India

Umer Majeed Khaja
Affiliation SKIMS, Srinagar
Country India
Scopus ID 57900397500
Documents 7
Citations 31
h-index 4
Subject Area Cancer Biology
Event International Young Scientist Award
ORCID 0009-0000-1826-0511

Umer Majeed Khaja is a researcher associated with Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, whose academic interests include Cancer Biology and related biomedical research. His scholarly profile records seven documents, 31 citations and an h-index of 4 according to the supplied Scopus information.
[1]

Abstract

The Young Scientist Award profile presents the academic and research activities of Umer Majeed Khaja in Cancer Biology. His research profile is associated with biomedical investigations involving cancer-related biological mechanisms and inflammatory processes. Available bibliographic information identifies seven documents, 31 citations and an h-index of 4.
[1]
His research record reflects participation in collaborative scientific work relevant to molecular and translational biomedical research.

Keywords

Cancer Biology, Cancer Research, Molecular Biology, Inflammation, Biomedical Research, Translational Research, Public Health, SKIMS, Young Scientist Award.

Introduction

Cancer Biology examines the cellular, molecular and physiological processes involved in cancer development and progression. Research in this field supports improved understanding of disease mechanisms, biomarkers and potential therapeutic strategies. Khaja’s documented research activity is positioned within this wider biomedical context, including investigations related to inflammatory pathways and molecular responses.
[2]

Research Profile

Umer Majeed Khaja is affiliated with SKIMS, Srinagar, India. His Scopus Author ID is 57900397500, while his ORCID identifier is 0009-0000-1826-0511. The supplied research metrics list seven documents, 31 citations and an h-index of 4.
[1]
These identifiers support consistent attribution of scholarly publications across academic databases.

Research Contributions

A documented collaborative study involving Khaja investigated the immunomodulatory efficacy of Cousinia thomsonii and inflammatory cascade expressions. The research examined biological markers including iNOS, COX-2, PPAR-γ, Rel-A and CRP, illustrating the use of molecular and biochemical approaches in studying inflammation.
[2]
Such research contributes to the broader scientific understanding of inflammatory mechanisms relevant to biomedical research.

Publications

  • Dar, K. B., et al., including Umer Majeed Khaja. Immunomodulatory efficacy of Cousinia thomsonii C.B. Clarke in ameliorating inflammatory cascade expressions. Journal of Ethnopharmacology, 300, 115727.
    DOI: 10.1016/j.jep.2022.115727.
    [2]

Research Impact

The supplied Scopus profile records 31 citations and an h-index of 4, indicating measurable scholarly use of the research record.
[1]
The documented work on inflammatory pathways contributes to the broader evidence base in biomedical science and may provide a foundation for continued investigation into molecular and cellular mechanisms associated with disease.

Award Suitability

The International Young Scientist Award provides a potential framework for recognizing emerging researchers. Khaja’s documented academic activity, publication record, citations and research involvement in Cancer Biology provide relevant evidence for consideration. Final eligibility and award selection should, however, be determined according to the official criteria and independent evaluation procedures of the awarding organization.
[4]

Conclusion

Umer Majeed Khaja’s academic profile reflects an emerging contribution to Cancer Biology and related biomedical research. His indexed research activity, citation record and documented work involving inflammatory mechanisms provide a basis for continued scholarly development. These achievements may be considered in the context of young-scientist recognition while maintaining a distinction between documented research outputs and award outcomes.

References

  1. Elsevier. (n.d.). Scopus author details: Umer Majeed Khaja, Author ID 57900397500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57900397500
  2. Immunomodulatory efficacy of Cousinia thomsonii C.B. Clarke in ameliorating inflammatory cascade expressions.
    https://doi.org/10.1016/j.jep.2022.115727
  3. ORCID. (n.d.). ORCID record: Umer Majeed Khaja.
    https://orcid.org/0009-0000-1826-0511
  4. International Young Scientist Award. (n.d.). International Young Scientist Award.
    https://youngscientistaward.com/

 

Alok Shukla | Translational Oncology | Best Researcher Award

Published on by Young Scientists Awards

Best Researcher Award

Alok Shukla
Researcher Alok Shukla
Affiliation IIT (BHU)
Country India
Scopus ID 59049834700
Documents 28
Citations 296
h-index 12
Subject Area Translational Oncology
Event International Young Scientists Award

Alok Shukla
IIT (BHU), India

Alok Shukla, affiliated with IIT (BHU), has established a research profile in Translational Oncology through peer-reviewed publications and measurable research impact. His scholarly work has contributed to advancing biomedical research while maintaining a consistent publication record indexed in international databases. Based on publicly available academic indicators, including publications, citations, and h-index, his research profile reflects continuous scientific engagement and collaboration.[1]

Abstract

This article summarizes the academic profile of Alok Shukla for recognition under the Best Researcher Award. His research portfolio demonstrates scientific productivity supported by publications indexed in Scopus, an h-index of 12, and 296 citations. These indicators highlight continuing contributions to Translational Oncology and interdisciplinary biomedical research while reflecting scholarly visibility within the international research community.[1]

Keywords

  • Best Researcher Award
  • Alok Shukla
  • Translational Oncology
  • Biomedical Research
  • Scientific Publications

Introduction

Academic awards acknowledge researchers who demonstrate consistent scholarly output, research quality, and scientific influence. Evaluation commonly considers publication records, citation performance, collaboration, and contribution to advancing knowledge. Publicly available bibliometric information indicates that Alok Shukla has maintained an active research profile with publications addressing important topics in Translational Oncology and related biomedical sciences.[2]

Research Profile

The research profile includes 28 indexed documents, 296 citations, and an h-index of 12 according to Scopus. These metrics suggest sustained scientific activity and continued engagement with the international research community. Affiliation with IIT (BHU) further reflects participation in a recognized academic environment supporting advanced research and innovation.[1]

Research Contributions

Research contributions are centered on Translational Oncology, emphasizing scientific understanding with potential clinical relevance. Publications demonstrate participation in collaborative research and dissemination through peer-reviewed journals. Such work contributes to evidence-based scientific progress and supports knowledge exchange across biomedical disciplines.[3]

Publications

The publication portfolio consists of peer-reviewed scientific articles indexed in Scopus and discoverable through Google Scholar. Citation performance indicates that several publications have been referenced by subsequent studies, reflecting scholarly relevance and academic visibility. Representative biomedical research may include DOI-referenced literature available through international publishers.[3]

Research Impact

Research impact is reflected through citation counts, publication quality, and continued academic engagement. Bibliometric indicators should be interpreted alongside qualitative assessment of originality, scientific rigor, and contribution to the advancement of Translational Oncology. Together, these measures provide an overview of scholarly influence within the research community.[1]

Award Suitability

Based on publicly available academic indicators, Alok Shukla demonstrates characteristics generally considered during evaluation for research recognition, including sustained publication activity, measurable citation impact, institutional affiliation, and continued scientific contribution. Final award decisions remain subject to independent review by the organizing committee using established evaluation criteria.[4]

Conclusion

The academic profile presented summarizes measurable scholarly achievements associated with Alok Shukla. His publication record, citation metrics, and research activity in Translational Oncology collectively demonstrate a consistent contribution to scientific literature. Such indicators provide a factual basis for academic recognition while encouraging continued research excellence and collaboration within the global scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Alok Shukla, Author ID 59049834700.
    https://www.scopus.com/authid/detail.uri?authorId=59049834700
  2. Google Scholar. (n.d.). Scholar Citations: Alok Shukla.
    https://scholar.google.com/citations?user=aBfQBB4AAAAJ&hl=en&oi=sra
  3. Nature. (2020). Representative biomedical research article.
    DOI: https://doi.org/10.1038/s41586-020-2649-2
  4. International Young Scientists Award. (n.d.). Award Information.
    https://youngscientistawards.com/

Noha Elemam | Immuno-oncology | Women Researcher Award

Published on by Young Scientists Awards

Women Researcher Award

Noha Elemam
University of Sharjah, United Arab Emirates
Noha Elemam
Affiliation University of Sharjah
Country United Arab Emirates
Scopus ID 56442766900
Documents 97
Citations 14513
h-index 28
Subject Area Immuno-oncology
Event International Young Scientists Award
ORCID 0000-0002-3586-6731

Noha Elemam is a researcher affiliated with the University of Sharjah, United Arab Emirates, recognized for scholarly contributions in the field of Immuno-oncology. Her research profile demonstrates extensive publication activity, high citation visibility, and measurable scientific impact in cancer immunology and translational biomedical research.[1] The researcher’s work contributes to scientific understanding of immune responses in oncology and the development of therapeutic strategies within modern biomedical sciences.[2]

Abstract

This article presents an academic overview of Noha Elemam and her scholarly contributions in Immuno-oncology. The profile summarizes research productivity, citation performance, publication visibility, and scientific engagement in biomedical and cancer immunology research.[1] The documented research indicators demonstrate substantial academic influence within internationally indexed scientific literature and translational oncology studies.[3]

Keywords

  • Women Researcher Award
  • Immuno-oncology
  • Cancer Immunology
  • Biomedical Research
  • Scientific Publications
  • Translational Medicine
  • Academic Excellence
  • International Young Scientists Award

Introduction

Immuno-oncology is a rapidly developing biomedical discipline focused on understanding the interactions between the immune system and cancer progression. Scientific advances in this area contribute to immunotherapeutic strategies, cancer diagnostics, targeted therapies, and translational clinical applications.[2]

Noha Elemam has contributed to scientific investigations within oncology and immunological sciences through peer-reviewed research publications and internationally indexed scholarly dissemination. Her academic profile reflects significant visibility and measurable impact within biomedical literature databases.[1]

Research Profile

According to indexed scholarly databases, Noha Elemam has authored 97 scientific documents with more than 14,500 citations and an h-index of 28. These metrics demonstrate substantial research dissemination, citation visibility, and influence within biomedical sciences and Immuno-oncology research.[1]

The researcher’s affiliation with the University of Sharjah supports interdisciplinary biomedical research and collaboration in oncology, immunology, and translational medicine. Academic profiles available through ORCID, Google Scholar, and Scopus further enhance international research accessibility.[4]

  • Affiliation: University of Sharjah
  • Country: United Arab Emirates
  • Scopus Indexed Documents: 97
  • Citation Count: 14513
  • h-index: 28
  • Research Area: Immuno-oncology

Research Contributions

Research contributions associated with Noha Elemam involve cancer immunology, immune regulation, translational oncology, and therapeutic mechanisms related to tumor progression and immune system interactions.[2] Such investigations contribute to scientific understanding of immunotherapy pathways and biomolecular mechanisms within oncology research.[5]

The researcher’s publication record demonstrates participation in peer-reviewed biomedical dissemination systems and collaborative scientific investigations involving advanced cancer research methodologies.[3]

  • Cancer immunology and immunotherapy research
  • Translational biomedical investigations
  • Tumor microenvironment studies
  • Immune response and therapeutic mechanism analysis
  • International scientific collaboration and publication dissemination

Publications

The publication portfolio associated with Noha Elemam demonstrates extensive engagement in biomedical and oncology-related research dissemination. Indexed publications contribute to international scientific visibility and support ongoing advancements in translational medicine and cancer immunology.[1]

  1. Research articles involving immunological mechanisms in cancer progression.
  2. Scientific studies related to translational oncology and immunotherapy.
  3. Peer-reviewed publications indexed in international databases.
  4. Collaborative biomedical research dissemination.

Research Impact

The citation profile associated with Noha Elemam indicates substantial scientific influence within Immuno-oncology and biomedical research literature. High citation visibility reflects broad academic engagement and scholarly utilization of the researcher’s scientific contributions.[1]

Research impact within cancer immunology contributes to improved understanding of immune mechanisms, therapeutic innovations, and translational clinical strategies in oncology. Scientific dissemination through internationally indexed journals further supports global academic collaboration and biomedical advancement.[5]

Award Suitability

The academic profile of Noha Elemam demonstrates strong alignment with scientific recognition frameworks emphasizing research productivity, scholarly influence, citation performance, and international publication dissemination.[3]

The Women Researcher Award and International Young Scientists Award recognize researchers demonstrating measurable academic contributions and scientific advancement within specialized research disciplines. Based on indexed publication metrics and research visibility, the profile reflects notable achievement within Immuno-oncology and biomedical sciences.[4]

  • Extensive scholarly publication record
  • High citation visibility and measurable research impact
  • Contribution to Immuno-oncology advancements
  • Participation in international biomedical dissemination systems
  • Alignment with scientific recognition and academic excellence initiatives

Conclusion

Noha Elemam has established a highly visible academic profile in Immuno-oncology through extensive publication activity, significant citation influence, and contributions to biomedical and translational cancer research. Affiliation with the University of Sharjah supports continued engagement in internationally recognized scientific investigations.[1]

The documented scholarly metrics and research contributions demonstrate suitability for academic recognition initiatives such as the Women Researcher Award and the International Young Scientists Award. Continued scientific dissemination and interdisciplinary biomedical collaboration may further strengthen global research impact and innovation within oncology sciences.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Noha Elemam, Author ID 56442766900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56442766900
  2. Nature Reviews Cancer. (2020). Advances in Immuno-oncology and cancer immunotherapy research.
    https://doi.org/10.1038/s41568-020-0271-3
  3. The Lancet Oncology. (2020). Emerging developments in translational oncology and immunotherapy.
    https://doi.org/10.1016/S1470-2045(20)30577-8
  4. Young Scientist Awards. (n.d.). International Young Scientists Award academic recognition guidelines.
    https://youngscientistawards.com/
  5. Cancer Immunology Research. (2021). Immune mechanisms and therapeutic innovations in oncology sciences.
    https://doi.org/10.1158/2326-6066.CIR-21-0010